Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population-Based Cohort.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
09 2020
Historique:
received: 28 01 2020
revised: 10 05 2020
accepted: 12 05 2020
pubmed: 4 6 2020
medline: 28 4 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

Identifying individuals at risk of developing Parkinson's disease (PD) is critical to define target populations for future neuroprotective trials. The objective of this study was to apply the PREDICT-PD algorithm of risk indicators for PD in a prospective community-based study (the Bruneck study), representative of the general elderly population. PREDICT-PD risk scores were calculated based on risk factor assessments obtained at baseline (2005, n = 574 participants). Cases of incident PD were identified at 5-year and 10-year follow-ups. Participants with PD or secondary parkinsonism at baseline were excluded (n = 35). We analyzed the association of log-transformed risk scores with the presence of well-established markers as surrogates for PD risk at baseline and with incident PD at follow-up. A total of 20 participants with incident PD were identified during follow-up (11 after 5 years and 9 after 10 years). Baseline PREDICT-PD risk scores were associated with incident PD with odds ratios of 2.09 (95% confidence interval, 1.35-3.25; P = 0.001) after 5 years and of 1.95 (1.36-2.79; P < 0.001) after 10 years of follow-up per doubling of risk scores. In addition, higher PREDICT-PD scores were significantly correlated with established PD risk markers (olfactory dysfunction, signs of rapid eye movement sleep behavior disorder and motor deficits) and significantly associated with higher probability for prodromal PD according to the Movement Disorder Society research criteria at baseline. The PREDICT-PD score was associated with an increased risk for incident PD in our sample and may represent a useful first screening step in future algorithms aiming to identify cases of prodromal PD. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND
Identifying individuals at risk of developing Parkinson's disease (PD) is critical to define target populations for future neuroprotective trials.
OBJECTIVE
The objective of this study was to apply the PREDICT-PD algorithm of risk indicators for PD in a prospective community-based study (the Bruneck study), representative of the general elderly population.
METHODS
PREDICT-PD risk scores were calculated based on risk factor assessments obtained at baseline (2005, n = 574 participants). Cases of incident PD were identified at 5-year and 10-year follow-ups. Participants with PD or secondary parkinsonism at baseline were excluded (n = 35). We analyzed the association of log-transformed risk scores with the presence of well-established markers as surrogates for PD risk at baseline and with incident PD at follow-up.
RESULTS
A total of 20 participants with incident PD were identified during follow-up (11 after 5 years and 9 after 10 years). Baseline PREDICT-PD risk scores were associated with incident PD with odds ratios of 2.09 (95% confidence interval, 1.35-3.25; P = 0.001) after 5 years and of 1.95 (1.36-2.79; P < 0.001) after 10 years of follow-up per doubling of risk scores. In addition, higher PREDICT-PD scores were significantly correlated with established PD risk markers (olfactory dysfunction, signs of rapid eye movement sleep behavior disorder and motor deficits) and significantly associated with higher probability for prodromal PD according to the Movement Disorder Society research criteria at baseline.
CONCLUSIONS
The PREDICT-PD score was associated with an increased risk for incident PD in our sample and may represent a useful first screening step in future algorithms aiming to identify cases of prodromal PD. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 32491231
doi: 10.1002/mds.28127
pmc: PMC7540037
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1658-1662

Subventions

Organisme : Parkinson's UK
ID : F-1201
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-1606
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Références

Neuroepidemiology. 1999;18(5):270-8
pubmed: 10461053
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52
pubmed: 2841426
Neuropathol Appl Neurobiol. 2016 Feb;42(1):33-50
pubmed: 26662475
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
Gerontology. 2019;65(1):9-19
pubmed: 30179866
Am J Epidemiol. 1982 Sep;116(3):547-53
pubmed: 7124721
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):31-7
pubmed: 23828833
Mov Disord. 2018 Mar;33(3):405-413
pubmed: 29436728
Ann Neurol. 2012 Dec;72(6):893-901
pubmed: 23071076
Eur J Epidemiol. 2016 Jul;31(7):679-84
pubmed: 26898908
Mov Disord. 2017 Jun;32(6):865-873
pubmed: 28429825
Mov Disord. 2017 Feb;32(2):219-226
pubmed: 28090684
J Parkinsons Dis. 2015;5(4):681-97
pubmed: 26485429
Cerebrovasc Dis. 2012;33(2):98-103
pubmed: 22156574
Brain. 1991 Oct;114 ( Pt 5):2283-301
pubmed: 1933245
Medicine (Baltimore). 2015 Jun;94(22):e952
pubmed: 26039136
Parkinsonism Relat Disord. 2020 Jan;70:51-54
pubmed: 31864071
Mov Disord. 2017 Jul;32(7):1025-1034
pubmed: 28509336
Mov Disord. 2019 May;34(5):665-675
pubmed: 30919499
Mov Disord. 2019 Oct;34(10):1464-1470
pubmed: 31412427

Auteurs

Kathrin Marini (K)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Philipp Mahlknecht (P)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Franziska Tutzer (F)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Heike Stockner (H)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Arno Gasperi (A)

Department of Neurology, Hospital of Bruneck, Bruneck, Italy.

Atbin Djamshidian (A)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Peter Willeit (P)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Stefan Kiechl (S)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
VASCage, Research Centre on Vascular Ageing and Stroke, Innsbruck, Austria.

Johann Willeit (J)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Gregorio Rungger (G)

Department of Neurology, Hospital of Bruneck, Bruneck, Italy.

Alastair J Noyce (AJ)

Department of Clinical and Movement Neurosciences, University College London Institute of Neurology, University College London, London, United Kingdom.
Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, United Kingdom.

Anette Schrag (A)

Department of Clinical and Movement Neurosciences, University College London Institute of Neurology, University College London, London, United Kingdom.

Werner Poewe (W)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Klaus Seppi (K)

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH